Table 1 Characteristics and demographic data of study population (n = 25)a
Parameter | Value |
|---|---|
Age (yr) | 61 ± 13 |
Gender (M/F) | 15/10 |
Weight (kg) | 75.3 ± 15.3 |
Height (cm) | 168.7 ± 7.8 |
Body surface area (m2) | 1.87 ± 0.19 |
Body mass index (kg m-2) | 24.5 ± 5.8 |
APACHE II score at admission | 17.7 ± 5.8 |
Plasma lactate level, mM/L | 2.16 (1.25 to 4.1) |
Death, n (%) | 11 (44) |
ICU stay before inclusion (days) | 1 (1 to 2) |
Ventilator settings | |
Tidal volume, mL/kg ideal body weight | 8.6 ± 1.2 |
Respiratory rate, breaths/min | 18.5 (17 to 20) |
Total PEEP, cm H2O | 7.9 ± 5.9 |
FiO2, % | 74 ± 19.6 |
SaO2, % | 98.5 (95 to 99) |
Vasoactive agents, n (dose in μg kg-1 min-1) | |
Norepinephrine | 12; 0.69 ± 0.39 |
Dobutamine | 3; 7.59 ± 1.31 |
Analgesic and sedative drugs | |
Morphine, n (dose in mg h-1) | 3; 4 (3.25 to 4.75) |
Fentanyl, n (dose in μg kg-1 h-1) | 8; 1.81 ± 0.6 |
Remifentanyl, n (dose in μg kg-1 min-1) | 11; 0.13 ± 0.07 |
Midazolam, n (dose in mg kg-1 h-1) | 14; 0.12 ± 0.05 |
Acute circulatory failure origin, n (%) | |
Sepsis | |
Abdominal | 11 (44) |
Pulmonary | 3 (12) |
Hemorrhagic shock | 4 (16) |
Postoperative | 4 (16) |
Others | 3 (12) |